Some of your friends may start to seem more distracted soon. One after another ADHD medication has been subjected to new scrutiny concerning possible major side effects, and now Strattera, the drug of choice for those attempting to avoid, e.g., the amphetamine-like effects of other ADD meds, or their effect on growth in children, is under fire in Sweden.
Urgent Safety Review of Strattera
Related posts
America Needs a Marshall Plan for Saving the Future of Science
At the end of World War Two, most of Europe lay in ruins. The Nazis had been defeated but at a terrible price to both the allied nations and the axis powers, including Germany. A former U.S. ally, the Soviet Union, had emerged as a dangerous threat to Europe. On June 5, 1947, in a […]
How do we Mentor in This Moment?
I don’t know how to be a good mentor right now and I’m mad about it. Almost as soon as I completed my PhD I was put into mentor roles even though I was in a professional place where I still needed mentoring myself. Because my path to a PhD and to bioethics was unusual […]
Confusion Over “Abortion” (And Why It Matters)
In Dobbs v. Jackson, the U.S. Supreme Court ruled that the Constitution does not confer a right to abortion. Instead, regulatory authority has been returned to individual states. A fragmented legal landscape has resulted, where laws vary dramatically—and often confusingly—across jurisdictions. Healthcare providers, patients, and policymakers must now ask: What counts as an abortion? This […]
AJOB ALERT: AJOB OPC Call Announcement Emails Now Sent via Constant Contact
Dear AJOB contributor, Starting with our most recent OPC call, AJOB has transitioned to sending Open Peer Commentary (OPC) call announcements via Constant Contact, rather than through the AJOB Editorial Site (ScholarOne). You’ll now receive OPC call emails from editor@ajob.ccsend.com. To ensure you don’t miss future announcements, please: To sign up to receive OPC call announcements, please […]